Literature DB >> 19761651

Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice.

F E Harrison1, J Allard, R Bixler, C Usoh, L Li, J M May, M P McDonald.   

Abstract

The present study investigated the relationships among oxidative stress, beta-amyloid and cognitive abilities in the APP/PSEN1 double-transgenic mouse model of Alzheimer's disease. In two experiments, long-term dietary supplements were given to aged APP/PSEN1 mice containing vitamin C alone (1 g/kg diet; Experiment 1) or in combination with a high (750 IU/kg diet, Experiments 1 and 2) or lower (400 IU/kg diet, Experiment 2) dose of vitamin E. Oxidative stress, measured by F(4)-neuroprostanes or malondialdehyde, was elevated in cortex of control-fed APP/PSEN1 mice and reduced to wild-type levels by vitamin supplementation. High-dose vitamin E with C was less effective at reducing oxidative stress than vitamin C alone or the low vitamin E+C diet combination. The high-dose combination also impaired water maze performance in mice of both genotypes. In Experiment 2, the lower vitamin E+C treatment attenuated spatial memory deficits in APP/PSEN1 mice and improved performance in wild-type mice in the water maze. Amyloid deposition was not reduced by antioxidant supplementation in either experiment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19761651      PMCID: PMC3730134          DOI: 10.1179/147683009X423364

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  83 in total

1.  Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.

Authors:  Hyoung-gon Lee; Xiongwei Zhu; Rudy J Castellani; Akihiko Nunomura; George Perry; Mark A Smith
Journal:  J Pharmacol Exp Ther       Date:  2007-01-17       Impact factor: 4.030

2.  Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid.

Authors:  Junjun Huang; James M May
Journal:  Brain Res       Date:  2006-05-24       Impact factor: 3.252

3.  Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms.

Authors:  David A Costa; Jennifer R Cracchiolo; Adam D Bachstetter; Tiffany F Hughes; Kelly R Bales; Steven M Paul; Ronald F Mervis; Gary W Arendash; Huntington Potter
Journal:  Neurobiol Aging       Date:  2006-05-26       Impact factor: 4.673

4.  Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse.

Authors:  Yoichiro Nishida; Takanori Yokota; Tsubura Takahashi; Toshiki Uchihara; Kou-ichi Jishage; Hidehiro Mizusawa
Journal:  Biochem Biophys Res Commun       Date:  2006-09-26       Impact factor: 3.575

5.  Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.

Authors:  Monica Garcia-Alloza; Elissa M Robbins; Sandy X Zhang-Nunes; Susan M Purcell; Rebecca A Betensky; Susan Raju; Claudia Prada; Steven M Greenberg; Brian J Bacskai; Matthew P Frosch
Journal:  Neurobiol Dis       Date:  2006-10-05       Impact factor: 5.996

6.  Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats.

Authors:  N G Kolosova; T V Shcheglova; S V Sergeeva; L V Loskutova
Journal:  Neurobiol Aging       Date:  2005-10-24       Impact factor: 4.673

7.  Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease.

Authors:  Veerendra Kumar Madala Halagappa; Zhihong Guo; Michelle Pearson; Yasuji Matsuoka; Roy G Cutler; Frank M Laferla; Mark P Mattson
Journal:  Neurobiol Dis       Date:  2007-01-13       Impact factor: 5.996

Review 8.  Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.

Authors:  Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Akihiko Nunomura; George Perry; Mark A Smith
Journal:  Acta Neuropathol       Date:  2006-04-27       Impact factor: 17.088

9.  Influence of oxidative stress on fusion of pre-synaptic plasma membranes of the rat brain with phosphatidyl choline liposomes, and protective effect of vitamin E.

Authors:  Nao-omi Omoi; Masaya Arai; Mitsunari Saito; Hirokatsu Takatsu; Akira Shibata; Kenji Fukuzawa; Kazue Sato; Kouichi Abe; Koji Fukui; Shiro Urano
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  2006-08       Impact factor: 2.000

10.  Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.

Authors:  R S Reiserer; F E Harrison; D C Syverud; M P McDonald
Journal:  Genes Brain Behav       Date:  2007-02       Impact factor: 3.449

View more
  27 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 2.  Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

Authors:  Magali Dumont; Michael T Lin; M Flint Beal
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Lentiviral-mediated knock-down of GD3 synthase protects against MPTP-induced motor deficits and neurodegeneration.

Authors:  Anandh Dhanushkodi; Yi Xue; Emily E Roguski; Yun Ding; Shannon G Matta; Detlef Heck; Guo-Huang Fan; Michael P McDonald
Journal:  Neurosci Lett       Date:  2018-11-01       Impact factor: 3.046

4.  Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics.

Authors:  T J Flanigan; Y Xue; S Kishan Rao; A Dhanushkodi; M P McDonald
Journal:  Genes Brain Behav       Date:  2014-04-22       Impact factor: 3.449

5.  Differential proteomic and behavioral effects of long-term voluntary exercise in wild-type and APP-overexpressing transgenics.

Authors:  Shailaja Kishan Rao; Jordan M Ross; Fiona E Harrison; Alexandra Bernardo; Randall S Reiserer; Ronald S Reiserer; James A Mobley; Michael P McDonald
Journal:  Neurobiol Dis       Date:  2015-03-25       Impact factor: 5.996

6.  Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease.

Authors:  Sönke Arlt; Tomas Müller-Thomsen; Ulrike Beisiegel; Anatol Kontush
Journal:  Neurochem Res       Date:  2012-08-10       Impact factor: 3.996

7.  Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice.

Authors:  John A Kennard; Fiona E Harrison
Journal:  Behav Brain Res       Date:  2014-02-05       Impact factor: 3.332

8.  Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

Authors:  Douglas R Galasko; Elaine Peskind; Christopher M Clark; Joseph F Quinn; John M Ringman; Gregory A Jicha; Carl Cotman; Barbara Cottrell; Thomas J Montine; Ronald G Thomas; Paul Aisen
Journal:  Arch Neurol       Date:  2012-07

9.  Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.

Authors:  Shilpy Dixit; Alexandra Bernardo; Jennifer Michelle Walker; John Andrew Kennard; Grace Youngeun Kim; Eric Sean Kessler; Fiona Edith Harrison
Journal:  ACS Chem Neurosci       Date:  2015-02-12       Impact factor: 4.418

10.  Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice.

Authors:  F E Harrison; J M May; M P McDonald
Journal:  Pharmacol Biochem Behav       Date:  2009-11-24       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.